Arkolith/Insider Trading/BRTX/Form 4

Alstodt Lance

President, CEO, COB, DirectorBioRestorative Therapies, Inc. (BRTX) · full profile →Form 4 · filed Jan 10, 2023
Net Buying
Open-Market Buys
$308
Open-Market Sells
$0
Net Open-Market Flow
$308
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 9, 2023Buy(P)100$3.08$308186K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-23-000770) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML